Specialty

Image description

Report: Patients facing growing challenges accessing orphan drugs

Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.

Image description

Diplomat Pharmacy registers to file IPO

Diplomat Pharmacy on Thursday announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.